2m 2m 2m 2m 2m 2m 2m
COMPASS THERAPTC (CMPX)
NASDAQ
$0.81-$0.03 (-3.70%)
Price as of Nov 11, 2026 6:58 PM EST- $150.9MMarket Cap
- -81.90%1-Year Change
- BiotechnologyIndustry
COMPASS THERAPTC (CMPX)
$0.81-$0.03 (-3.70%)
CMPX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.84 | ||
Change | +$0.001 (+0.13%) | ||
Open | $0.85 | ||
High | $0.90 | ||
Low | $0.83 | ||
Previous Close | $0.84 | ||
Volume | 2,118,942 | ||
30-Day Average Volume | 2,501,896 | ||
1-Week Change | 11.29% | ||
1-Month Change | -15.61% | ||
1-Year Change | -81.90% | ||
3-Year Change | -45.94% | ||
5-Year Change | -76.79% | ||
Fundamentals | |||
Shares Outstanding | 180.1M | ||
Total Assets | $174.5M | ||
Market Cap | $150.9M | ||
Enterprise Value | $109.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$27.2M | ||
Free Cash Flow | -$16.4M | ||
EBIT | -$27.2M | ||
EBITDA | -$27.1M | ||
Net Working Capital | $141.1M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -6 | ||
PEG | 0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue